|
NDUFA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.061400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.682000E-01 |
| Normal-vs-Stage2 |
9.889000E-01 |
| Normal-vs-Stage3 |
6.290000E-02 |
| Normal-vs-Stage4 |
8.526000E-01 |
| Stage1-vs-Stage2 |
7.210000E-01 |
| Stage1-vs-Stage3 |
1.873770E-02 |
| Stage1-vs-Stage4 |
9.597800E-01 |
| Stage2-vs-Stage3 |
2.002400E-01 |
| Stage2-vs-Stage4 |
8.728600E-01 |
| Stage3-vs-Stage4 |
1.894350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.025000E-01 |
| Normal-vs-AfricanAmerican |
3.024600E-01 |
| Normal-vs-Asian |
6.813400E-01 |
| Caucasian-vs-AfricanAmerican |
2.017400E-01 |
| Caucasian-vs-Asian |
5.707200E-01 |
| AfricanAmerican-vs-Asian |
4.036000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.240800E-01 |
| Normal-vs-Female |
1.262200E-01 |
| Male-vs-Female |
8.304300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.987000E-01 |
| Normal-vs-Extreme_Weight |
3.511200E-01 |
| Normal-vs-Obese |
7.578400E-01 |
| Normal-vs-Extreme_Obese |
2.255400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.919600E-01 |
| Normal_Weight-vs-Obese |
9.914600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.823410E-01 |
| Extreme_Weight-vs-Obese |
2.236400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.733400E-01 |
| Obese-vs-Extreme_Obese |
1.405610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.767210E-01 |
| Normal-vs-Age(41-60Yrs) |
3.500400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.459600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.512800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.067580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.707800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.916000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.334980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.026000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.277200E-03 |
| Normal-VS-Type2 PRCC |
7.202500E-03 |
| Normal-VS-KIRP CIMP |
1.13840000004473E-06 |
| Normal-VS-Unclassified PRCC |
1.094210E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.42460487850826E-11 |
| Type1 PRCC-VS-KIRP CIMP |
3.18170045865429E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
5.74199999999747E-05 |
| Type2 PRCC-VS-KIRP CIMP |
3.5913000000054E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.718800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.08840000000188E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.498600E-01 |
| Normal-vs-N1 |
5.763100E-03 |
| Normal-vs-N2 |
4.862200E-02 |
| N0-vs-N1 |
5.777600E-02 |
| N0-vs-N2 |
2.096800E-01 |
| N1-vs-N2 |
7.329800E-01 |
|
|
